These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 19875680)

  • 1. Quantitative risk analysis for N-methyl pyrrolidone using physiologically based pharmacokinetic and benchmark dose modeling.
    Poet TS; Kirman CR; Bader M; van Thriel C; Gargas ML; Hinderliter PM
    Toxicol Sci; 2010 Feb; 113(2):468-82. PubMed ID: 19875680
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using physiologically based pharmacokinetic modeling and benchmark dose methods to derive an occupational exposure limit for N-methylpyrrolidone.
    Poet TS; Schlosser PM; Rodriguez CE; Parod RJ; Rodwell DE; Kirman CR
    Regul Toxicol Pharmacol; 2016 Apr; 76():102-12. PubMed ID: 26776754
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
    Marsman D
    Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Workplace environmental exposure level guide: n-Methyl-2-pyrrolidone.
    Toxicol Ind Health; 2022 Jun; 38(6):309-329. PubMed ID: 35658636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentrations of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine following oral administration of NMP to rats.
    Carnerup MA; Saillenfait AM; Jönsson BA
    Food Chem Toxicol; 2005 Sep; 43(9):1441-7. PubMed ID: 15951091
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human experimental exposure to N-methyl-2-pyrrolidone (NMP): toxicokinetics of NMP, 5-hydroxy- N-methyl-2-pyrrolidone, N-methylsuccinimide and 2-hydroxy- N-methylsuccinimide (2-HMSI), and biological monitoring using 2-HMSI as a biomarker.
    Jönsson BA; Akesson B
    Int Arch Occup Environ Health; 2003 May; 76(4):267-74. PubMed ID: 12684812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE; Walker DM; Meng Q; McDonald JD; Scott BR; Seilkop SK; Claffey DJ; Upton PB; Powley MW; Swenberg JA; Henderson RF;
    Res Rep Health Eff Inst; 2009 Aug; (144):3-79. PubMed ID: 20017413
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Using physiologically-based pharmacokinetic modeling to address nonlinear kinetics and changes in rodent physiology and metabolism due to aging and adaptation in deriving reference values for propylene glycol methyl ether and propylene glycol methyl ether acetate.
    Kirman CR; Sweeney LM; Corley R; Gargas ML
    Risk Anal; 2005 Apr; 25(2):271-84. PubMed ID: 15876203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human experimental exposure study on the uptake and urinary elimination of N-methyl-2-pyrrolidone (NMP) during simulated workplace conditions.
    Bader M; Wrbitzky R; Blaszkewicz M; van Thriel C
    Arch Toxicol; 2007 May; 81(5):335-46. PubMed ID: 17103143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multigenerational reproductive study of genistein (Cas No. 446-72-0) in Sprague-Dawley rats (feed study).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Mar; (539):1-266. PubMed ID: 18685713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicology and carcinogenesis studies of propargyl alcohol (CAS No. 107-19-7) in F344/N rats and B6C3F1 mice (inhalation studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2008 Sep; (552):1-172. PubMed ID: 18974778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of N-methyl-2-pyrrolidone (NMP) and its metabolites in plasma and urine from volunteers after experimental exposure to NMP in dry and humid air.
    Carnerup MA; Spanne M; Jönsson BA
    Toxicol Lett; 2006 Apr; 162(2-3):139-45. PubMed ID: 16321482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemosensory effects during acute exposure to N-methyl-2-pyrrolidone (NMP).
    van Thriel C; Blaszkewicz M; Schäper M; Juran SA; Kleinbeck S; Kiesswetter E; Wrbitzky R; Stache J; Golka K; Bader M
    Toxicol Lett; 2007 Dec; 175(1-3):44-56. PubMed ID: 17981408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Monograph for N-Methyl-pyrrolidone (NMP) and human biomonitoring values for the metabolites 5-Hydroxy-NMP and 2-Hydroxy-N-methylsuccinimide].
    Bekanntmachung des Umweltbundesamtes
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2015 Oct; 58(10):1175-91. PubMed ID: 26324095
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of CYP2E1 to N-methyl-2-pyrrolidone metabolism.
    Ligocka D; Lison D; Haufroid V
    Arch Toxicol; 2003 May; 77(5):261-6. PubMed ID: 12734639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dermal absorption and urinary elimination of N-methyl-2-pyrrolidone.
    Bader M; Keener SA; Wrbitzky R
    Int Arch Occup Environ Health; 2005 Sep; 78(8):673-6. PubMed ID: 16001206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human volunteer study on the influence of exposure duration and dilution of dermally applied N-methyl-2-pyrrolidone (NMP) on the urinary elimination of NMP metabolites.
    Keener SA; Wrbitzky R; Bader M
    Int Arch Occup Environ Health; 2007 Feb; 80(4):327-34. PubMed ID: 16897094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Final report on the safety assessment of methoxyisopropanol and methoxyisopropyl acetate as used in cosmetics.
    Cosmetic Ingredient Review Expert Panel
    Int J Toxicol; 2008; 27 Suppl 2():25-39. PubMed ID: 18830862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neonatal mortality from in utero exposure to perfluorooctanesulfonate (PFOS) in Sprague-Dawley rats: dose-response, and biochemical and pharamacokinetic parameters.
    Luebker DJ; York RG; Hansen KJ; Moore JA; Butenhoff JL
    Toxicology; 2005 Nov; 215(1-2):149-69. PubMed ID: 16129535
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human volunteer study on the inhalational and dermal absorption of N-methyl-2-pyrrolidone (NMP) from the vapour phase.
    Bader M; Wrbitzky R; Blaszkewicz M; Schäper M; van Thriel C
    Arch Toxicol; 2008 Jan; 82(1):13-20. PubMed ID: 17721780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.